DBV Technologies S.A. - American Depositary Shares - Mali Tablolar (NASDAQ:DBVT) | MetaTrader

Tam grafiği aç Full chart

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Haberler

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

DBV Technologies: A Cohort-Driven Model That Could Support Blockbuster VIASKIN Revenue

DBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock?

Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know

DBV Technologies: A Tough Nut To Crack In A Shrinking Market (NASDAQ:DBVT)

Cantor Fitzgerald, DBV Technologies için hedef fiyatı korudu

Cantor Fitzgerald, DBV Technologies hissesi için Overweight görüşünü yineledi

Citizens, alerji ilacı görünümüyle DBV Technologies hisse hedefini yükseltti

Citizens, DBV Technologies hissesi için hedef fiyatını korudu

Citizens reiterates DBV Technologies stock rating on Viaskin Peanut potential

DBV Technologies hissesi yeni fıstık yaması deneme verileriyle yükseldi

DBV Technologies stock surges on new peanut patch trial data